1 / 22

Hereditary Factors in Breast Cancer

Hereditary Factors in Breast Cancer. Jessica Ray, MS, CGC Genetic Counselor. OBJECTIVES:. Discuss who should consider genetic counseling and genetic testing Discuss risks for cancers associated with BRCA1/2 mutation Cancer Risk Reduction Options Important Points of Genetic Testing

nevaeh
Download Presentation

Hereditary Factors in Breast Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hereditary Factors in Breast Cancer Jessica Ray, MS, CGC Genetic Counselor

  2. OBJECTIVES: • Discuss who should consider genetic counseling and genetic testing • Discuss risks for cancers associated with BRCA1/2 mutation • Cancer Risk Reduction Options • Important Points of Genetic Testing • Cost of Genetic Testing and Insurance Issues

  3. Reasons for Seeking Genetics Consultation • To learn about • Personal risk for cancer • Children’s risk for cancer • Family’s risk for cancer • Risks for developing cancer if you have a “cancer gene” • Recommendations for screening, surveillance, and/or treatment • Educational information • To obtain genetic DNA testing J Med Genet 2000; 37:866-874

  4. Key Flags that Warrant Genetic Counseling • Significant family medical history-breast, ovarian, prostate, colon, melanoma, pancreatic, or other cancers • Cancer occurs in every generation • Early age of onset (< 50 years) • Male breast cancer • Bilateral cancer, or multiple primary cancers in one individual • Known family genetic mutation • Ethnicity – Ashkenazi Jewish ancestry

  5. A BRCA Mutation Increases Risk of Second Cancer Up to 64% General Population 60 BRCA Mutation Up to 27% 40 Risk of Cancer (%) Up to 11% 16% 20 Up to 11% * 0 Ovarian Cancer Breast Cancer Breast Cancer by after 5 yrs age 70 * no statistic available JNCI 1999;15:1310-6 JCO 1998;16:2417-25 Lancet 1998;351:316-21 JCO 2004;22:2328-35 Lancet 1994;3343:692-5

  6. Breast 41 Prostate 63 Ovarian 40-50 Breast 62 Prostate 71 Ovarian 60 Average Age of DiagnosisHereditarySporadic

  7. RISK REDUCTION OPTIONS • Surveillance • Alternate Mammogram and Breast MRI every 6 months • CA-125 and Pelvic/Ovarian Ultrasound annually • Prophylactic Surgeries • Prophylactic Bilateral/Unilateral Mastectomy = 90% reduction in breast cancer risk • Prophylactic Bilateral Oophorectomy = 96% reduction in ovarian cancer risk • If PBO performed pre-menopausally, also gives a 50% reduction in breast cancer risk • Chemoprevention • Tamoxifen, Raloxifene

  8. When Do You Offer Testing? • American Society of Clinical Oncology recommends offering genetic testing when: • The individual has a personal or family history of features suggestive of a genetic cancer susceptibility condition • The test can be adequately interpreted • The results will aid in diagnosis or influence the medical or surgical management of the patient or family members at hereditary risk of cancer

  9. ASCO recommends genetic testing only in the setting of pre- and post-test counseling, which should includes discussion of possible risks and benefits of cancer early detection and prevention modalities

  10. Commercial BRCA testing • BRCA1 and BRCA2 testing is available only at Myriad Genetic Laboratories • In 2001, added 5 specific large rearrangements in BRCA1 • August 2006, new panel added to detect large rearrangement in both BRCA1 and BRCA2 • Cost of full sequencing of both BRCA1 and BRCA2 genes is $4,000, Cost of testing for a known family mutation is $475

  11. GINA-Genetic Information Nondiscrimination Act • Prohibits use of an individual’s genetic information in setting eligibility or premium or contribution amounts by group and individual insurers • Prohibits health insurers from requesting or requiring an individual to take a genetic test • Does not prohibit medical underwriting based on current health status • Prohibits use of an individual’s genetic information by employers in employment decisions such as hiring, firing, job assignments, and promotions • Prohibits employers from requesting, requiring, or purchasing information about an individual employee or family member

  12. Final Take Home Message • Evidence that many women overestimate their risk of developing breast cancer • Genetic testing may provide accurate risk assessments for both breast and ovarian cancer • Not everyone found to have a BRCA1/2 mutation will develop cancer! • Negative genetic test result DOES NOT mean No Increased Risk!! • What do we offer women at high risk for breast and ovarian cancer who test negative commercially for a BRCA1/2 mutation? • HIGH RISK BREAST CANCER CLINIC AT AZCC

More Related